US › Healthcare

Nutriband Inc (NTRB)

US · Healthcare · Biotechnology

$7.65+8.66%

Last close · 2026-09-17

Latest quarter · ended 2026-07-31

Revenue

$437,514

Revenue YoY

-29.7%

Net profit

$-880,561

EPS

$-0.07

Net margin

-201.3%

Key statistics

Market cap

$84.6M

Forward P/E

370.4

P/B

15.80

Book value

$0.44

EPS (TTM)

$-0.49

52-week high

$8.63

52-week low

$2.80

50-day MA

$3.72

200-day MA

$3.99

Beta

2.04

Analyst view

Analysts rate Nutriband Inc a strong buy (1 buy, 0 hold, 0 sell out of 1) with an average price target of $15.00.

Shareholding

Insiders

56.82%

Institutions

2.90%

Largest institutional holders

Fund	Stake
Vanguard Capital Management, LLC	1.44%
Geode Capital Management, LLC	0.58%
UBS Group AG	0.27%
Vanguard Fiduciary Trust Co	0.21%
State Street Corp	0.21%
Citadel Advisors Llc	0.16%
Northern Trust Corp	0.11%
Haven Private, LLC	0.09%

See the full picture

Technicals, trade setups with a published hit rate, AI analysis and earnings-call summaries for Nutriband Inc — free to start.

Google Play App Store

Other Healthcare companies

Eli Lilly and Company Johnson & Johnson AbbVie Inc Merck & Company Inc UnitedHealth Group Incorporated Novartis AG ADR AstraZeneca PLC Thermo Fisher Scientific Inc Amgen Inc Novo Nordisk A/S Gilead Sciences Inc Abbott Laboratories

Data updated 2026-09-18.